Kymera Therapeutics (KYMR) Stock: Buy, Sell, or Hold?
KYMR - Kymera Therapeutics, Inc. Common Stock
$114.96
-2.04 (-1.74%)
âŧ
5d:
-1.98%
30d:
+0.82%
90d:
+38.57%
WAIT
LOW Confidence
Analysis Updated: Sep 11, 2026 12:00 AM ET
Earnings: Nov 03, 2026
Get Alerted When KYMR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: KYMR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: KYMR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: KYMR is currently trading at $114.96, which is considered fair relative to its 30-day fair value range of $110.62 to $122.66.
Technical Outlook: Technically, KYMR is in a strong uptrend. The price is currently testing key support at $112.77. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: KYMR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $134.71 (+17.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, KYMR is in a strong uptrend. The price is currently testing key support at $112.77. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: KYMR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $134.71 (+17.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$110.62 -
$122.66
Company Quality Score
47/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
58.3%
Protect Your Profits
Holding KYMR? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($134.71)
- WARNING: Composite score 47/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$110.62 -
$122.66
Current vs Trading Range
FAIR
Expected Move (7 Days)
Âą$11.05
(9.6%)
Support & Resistance Levels
Support Level
$112.77
Resistance Level
$123.54
Current Trend
Strong Uptrend
Technical data as of
Sep 11, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-23.21
Wall Street Target
$134.71
(+17.2%)
Revenue Growth (YoY)
466.4%
Profit Margin
-285.3%
Share & Embed Analysis
Last updated: September 12, 2026 6:40 PM ET
Data refreshes hourly during market hours. Next update: 7:40 PM
Data refreshes hourly during market hours. Next update: 7:40 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is KYMR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
17
Sells
Net
INSIDERS SELLING
Recent Transactions
Bruce Booth
SELL
5900 shares
2026-04-22
Jeremy G Chadwick
SELL
300 shares
2026-04-22
Bruce Booth
SELL
100 shares
2026-04-22
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$24 | 32 SELL |
|
REGN
Regeneron PharmaceuticalâĻ |
STRONG BUY
25 analysts |
$840 | 50 HOLD |
|
JAZZ
Jazz Pharmaceuticals PLC |
STRONG BUY
18 analysts |
$289 | 59 HOLD |
|
MLTX
MoonLake ImmunotherapeutâĻ |
STRONG BUY
16 analysts |
$29 | 41 HOLD |
|
ACAD
ACADIA Pharmaceuticals IâĻ |
BUY
20 analysts |
$34 | 52 HOLD |
Advanced KYMR Option Strategies
Professional options setups generated by AI based on today's KYMR price and gamma walls.
